Background: A 75-year-old female presented with a 1 month history of nonbloody diarrhea, associated with abdominal cramping and urgency. Her medical history was notable for chronic myelomonocytic ...

The biotech’s lead drug candidate is already in Phase 1 development for treating advanced hematologic malignancies including chronic myelomonocytic leukemia (CMML), a rare type of blood cancer.